Medicare Enrolled

Dr. Wade Aubry, M.D

Endocrinology · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
909 HYDE ST STE 125, San Francisco, CA 94109
4157714366
In practice since 2006 (19 years)
NPI: 1447265814 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aubry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aubry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aubry

Dr. Wade Aubry is an endocrinology specialist in San Francisco, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aubry performed 184 Medicare services across 90 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aubry received a total of $89,596 from 14 pharmaceutical and/or device companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aubry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 184 Medicare services $89,596 industry payments

Medicare Practice Summary

Medicare Utilization ↗
184
Medicare services
Bottom 19% in CA for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
90
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nursing facility visit, established patient, straightforward
A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes.
 73 $33 $96
Nursing facility visit, low complexity
A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care.
 58 $58 $169
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 28 $79 $202
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 25 $116 $289
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2023 ↗
$89,596
Total received (2018-2023)
Avg $14,933/year across 6 years
Top 5% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
51
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$84,157 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,990 (4.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,449 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$2,750
2022
$9,986
2021
$11,500
2020
$28,050
2019
$26,759
2018
$10,551

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$2,750
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Greenwich Biosciences, Inc.
$37,750
EMD Serono, Inc.
$13,166
VERTEX PHARMACEUTICALS INCORPORATED
$6,810
EKOS Corporation
$4,950
PneumRx, Inc
$4,800
Pear Therapeutics (US), Inc.
$4,200
NOVARTIS PHARMACEUTICALS CORPORATION
$3,990
ABBVIE INC.
$3,206
Allergan Inc.
$3,026
Ferring Pharmaceuticals Inc.
$2,750
JAZZ PHARMACEUTICALS INC.
$2,500
Endogastric Solutions, Inc
$1,800
Novartis Pharmaceuticals Corporation
$568
AbbVie Inc.
$80
Top 3 companies account for 64.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · BEOVU · Bavencio · EKOSONIC · ESOPHYX · Epidiolex · PNEUMRX COILS · REBYOTA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (94%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for endocrinology in CA.

Looking for an endocrinology specialist in San Francisco?
Compare endocrinologists in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
85
Per 100K population
10.2
County median income
$141,446
Nearest hospital
CALIFORNIA PACIFIC MEDICAL CENTER- VAN NESS CAMPUS
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2023
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aubry is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aubry experienced with nursing facility visit, established patient, straightforward?
Based on Medicare claims data, Dr. Aubry performed 73 nursing facility visit, established patient, straightforward services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aubry receive payments from pharmaceutical companies?
Yes. Dr. Aubry received a total of $89,596 from 14 companies across 51 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aubry's costs compare to other endocrinologists in San Francisco?
Dr. Aubry's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aubry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in San Francisco
Browse endocrinologists in San Francisco ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Greenwich Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Greenwich Biosciences, Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
VERTEX PHARMACEUTICALS INCORPORATED Payments to Doctors
See all physicians who received payments from VERTEX PHARMACEUTICALS INCORPORATED.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →